News

Sandoz announced a global resolution of all intellectual property (IP) related litigation with AbbVie concerning the proposed Sandoz biosimilar Hyrimoz (adalimumab) for reference…
Read More...

Almac Group announced the completion of an investment in its Durham, North Carolina Clinical Services’ and Diagnostic Services’ capabilities with the opening of a 24,000 sq. ft.…
Read More...

Bristol-Myers Squibb Company and Compugen announced the companies have entered into a clinical trial collaboration to evaluate the safety and tolerability of Compugen’s COM701, an…
Read More...

The first clinical trial of a completely novel and unprecedented approach to modifying the progression of Alzheimer's disease has opened in London. The study is being conducted in the…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) seeking…
Read More...

Allergan has joined the TriNetX global health research network for real-time access to patient populations, driven and refreshed by clinical data, to determine protocol feasibility,…
Read More...

ROSLINCT announced it is to receive investment to collaborate with REPROCELL Europe Ltd (REPROCELL), a UK-based stem cell company, on a £1.2 million project which will develop a faster,…
Read More...

The Mundipharma global network of independent associated companies has added development capabilities to its biosimilars platform with the purchase of biosimilars development company…
Read More...

Ionis Pharmaceuticals announced a new collaboration with Roche to develop IONIS-FB-LRx for the treatment of complement-mediated diseases. This collaboration will leverage Ionis'…
Read More...

Marina Biotech announced that it has changed its name to Adhera Therapeutics and that it will begin using the ticker ATRX, in each case effective October 9, 2018. This new name reflects…
Read More...

Recipharm has released its first serialised products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden. In 2016 Recipharm committed to invest 40 million euros…
Read More...

USP is announcing a new program to assist manufacturers in their drug development efforts—Impurities for Development (IfD). This new program can help pharmaceutical manufacturers meet…
Read More...

Noramco, a leader in controlled substances and cannabinoids, is adding commercial-scale capacity of dronabinol (THC) at its Athens, Georgia, United States facility. The expansion comes…
Read More...

Neurocrine Biosciences and Jnana Therapeutics announced that they have entered into a research collaboration aimed at discovering novel small molecule therapeutics for multiple targets…
Read More...

Shanghai UniCAR-Therapy Bio-Medicine Technology Co. chose Terumo BCT and its cell expansion devices to automate its cell therapy manufacturing process for chimeric antigen receptor…
Read More...

Wave Life Sciences Ltd. announced plans to design and advance stereopure oligonucleotide therapeutics for the potential treatment of rare, inherited eye diseases. Wave’s research in…
Read More...

Novartis announced that both the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) have accepted the company's New Drug Application (NDA) and Marketing…
Read More...

Sarepta Therapeutics announced that it has entered into a long-term strategic manufacturing partnership with Paragon Bioservices (Paragon), which will provide Sarepta access to…
Read More...

Novan announced that the Company has expanded its partnership with Sato Pharmaceutical, a Japanese company with a prescription pharmaceutical business specializing in dermatology, to…
Read More...

Amicus Therapeutics announced a major collaboration with the Gene Therapy Program in the Perelman School of Medicine at the University of Pennsylvania (Penn) to pursue research and…
Read More...